Alzheimer's Biotech Leads Trio Of IPOs To Raise $428M Total
Athira Pharma, a biopharmaceutical company focused on preventing neurodegenerative diseases like Alzheimer's, led a trio of companies that kicked off trading Friday in initial public offerings that raised a total $428...To view the full article, register now.
Already a subscriber? Click here to view full article